Branch atheromatous disease and treatment

Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Honglian, Yun, Ho Jun, Geng, Xiaokun, Ding, Yuchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167853/
https://www.ncbi.nlm.nih.gov/pubmed/37181840
http://dx.doi.org/10.4103/bc.bc_56_22
_version_ 1785038752542883840
author Duan, Honglian
Yun, Ho Jun
Geng, Xiaokun
Ding, Yuchuan
author_facet Duan, Honglian
Yun, Ho Jun
Geng, Xiaokun
Ding, Yuchuan
author_sort Duan, Honglian
collection PubMed
description Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis.
format Online
Article
Text
id pubmed-10167853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-101678532023-05-10 Branch atheromatous disease and treatment Duan, Honglian Yun, Ho Jun Geng, Xiaokun Ding, Yuchuan Brain Circ Perspective Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis. Wolters Kluwer - Medknow 2022-12-06 /pmc/articles/PMC10167853/ /pubmed/37181840 http://dx.doi.org/10.4103/bc.bc_56_22 Text en Copyright: © 2022 Brain Circulation https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Perspective
Duan, Honglian
Yun, Ho Jun
Geng, Xiaokun
Ding, Yuchuan
Branch atheromatous disease and treatment
title Branch atheromatous disease and treatment
title_full Branch atheromatous disease and treatment
title_fullStr Branch atheromatous disease and treatment
title_full_unstemmed Branch atheromatous disease and treatment
title_short Branch atheromatous disease and treatment
title_sort branch atheromatous disease and treatment
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167853/
https://www.ncbi.nlm.nih.gov/pubmed/37181840
http://dx.doi.org/10.4103/bc.bc_56_22
work_keys_str_mv AT duanhonglian branchatheromatousdiseaseandtreatment
AT yunhojun branchatheromatousdiseaseandtreatment
AT gengxiaokun branchatheromatousdiseaseandtreatment
AT dingyuchuan branchatheromatousdiseaseandtreatment

Ejemplares similares